Dr. Lee is the holder of the Meredith Mosle Chair in Liver Diseases since 2003. He leads a large clinical trials group at UT Southwestern performing pharmaceutical studies of new treatments for hepatitis B and C as well as NIH-sponsored research (The HALT-C Trial). He was the founding Principal Investigator for the Acute Liver Failure Study Group (ALFSG) that has been funded by NIDDK and based at UT Southwestern since 1998. His lab is exploring the molecular basis of hepatitis C viral resistance to therapy.
RESEARCH INTERESTS
Viral hepatitis
Acute liver failure
RECENT PUBLICATIONS
Lee WM, "Medical Progress: Drug-Induced Hepatotoxicity" N Engl J Med, 349:474-85, 2003
Lee WM, Squires RH Jr, Nyberg SL, Doo E, Hoofnagle JH, "Acute Liver Failure: Summary of a Workshop." Hepatology, 2008;:47::1401-15
Lee WM, Dienstag JL, Lindsay KL, et al., "Evolution of the HALT-C Trial: pegylated interferon as maintenance therapy for chronic hepatitis C in previous interferon non-responders." Contr Clin Trials, 25:472-92., 2004
Point and right click (click and hold for Mac users) your mouse onand select "Save this link (or target) as..." option to save the file to your local computer.
and select "Save this link (or target) as..." option to save the file to your local computer.